Nama Insights

Abbott Laboratories (ABT)

Healthcare · Medical Devices · NYSE

S&P 500
Abbott Laboratories (ABT) is a Healthcare company in the Medical Devices industry. It has a market capitalization of $186.55B, a trailing price-to-earnings ratio of 20.5 and a free-cash-flow yield of 3.9%. Over the most recent reported fiscal year, revenue grew 5.7% and free cash flow per share grew 16.4%.
Market cap$186.55B
Trailing P/E20.5
FCF yield3.9%
Revenue growth (YoY)+5.7%
EPS growth (YoY)+10.3%
FCF/share growth (YoY)+16.4%
ExchangeNYSE
SectorHealthcare
IndustryMedical Devices
Explore live ABT data on Nama Insights →

Recent Congressional trades

Abbott Laboratories trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Rick Larsen House Sell $1,001 - $15,000 Jul 9, 2026
Richard Dean Dr McCormick House Buy $1,001 - $15,000 Jul 8, 2026
Gilbert Cisneros House Buy $1,001 - $15,000 Jul 2, 2026
Gilbert Cisneros House Sell $1,001 - $15,000 Jun 5, 2026
Julie Johnson House Sell $1,001 - $15,000 Jun 3, 2026
Richard W. Allen House Sell $15,001 May 4, 2026
Laura Friedman House Exchange $1,001 - $15,000 Apr 3, 2026
Julie Johnson House Sell $1,001 - $15,000 Jan 5, 2026
Byron Donalds House Sell $1,001 - $15,000 Jan 1, 2026
Lisa McClain House Buy $1,001 - $15,000 Aug 13, 2025
Julia Letlow House Buy $1,001 - $15,000 Aug 11, 2025
Jefferson Shreve House Sell $50,001 - $100,000 May 15, 2025